Evelo Biosciences Inc (CE) (EVLO)
USOTC
年末 2022年12月31日 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
総売上 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
営業利益 | -13.03M | -27.53M | -58.1M | -86.36M | -91.89M | -115.4M | -108.47M |
税引前収入 | -13.33M | -28.05M | -56.95M | -85.28M | -93.26M | -121.75M | -113.6M |
純利益 | -14.98M | -34.13M | -60.88M | -85.47M | -93.67M | -122.18M | -114.53M |
優先配当 | -1.65M | -6.09M | -3.94M | 0 | 0 | 0 | 0 |
基本的1株当たり利益 (EPS) | -1.015 | -2.156 | -1.913 | -2.657 | -1.973 | -2.28 | -1.033 |
EBIT | -13.05M | -27.83M | -58.51M | -86.33M | -91.15M | -114.91M | -108.41M |
EBITDA | -12.53M | -26.7M | -56.17M | -84.56M | -89.86M | -113.18M | -106.41M |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約